Cancer Therapy-Related Cardiac Dysfunction of Nonanthracycline Chemotherapeutics: What Is the Evidence?

Cancer therapy–related cardiac dysfunction (CTRCD) is one of the most concerning cardiovascular side effects of cancer treatment. Important reviews within the field of cardio-oncology have described various agents to be associated with a high risk of CTRCD, including mitomycin C, ifosfamide, vincris...

Descripción completa

Detalles Bibliográficos
Autores principales: Kamphuis, Janine A.M., Linschoten, Marijke, Cramer, Maarten J., Gort, Eelke H., van Rhenen, Anna, Asselbergs, Folkert W., Doevendans, Pieter A., Teske, Arco J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Primers in Cardio-Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8352330/
https://www.ncbi.nlm.nih.gov/pubmed/34396190
http://dx.doi.org/10.1016/j.jaccao.2019.09.007

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8352330/
https://www.ncbi.nlm.nih.gov/pubmed/34396190
http://dx.doi.org/10.1016/j.jaccao.2019.09.007

Ejemplares similares